TBAJ876
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TBAJ876, covering 2025-02-17 to 2025-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis [Phase 2]